Crown Electrokinetics Corp. Common Stock
CRKN
CRKN was delisted on the 4th of March, 2025.
1 hedge funds and large institutions have $339K invested in Crown Electrokinetics Corp. Common Stock in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
28% more capital invested
Capital invested by funds: $265K → $339K (+$73.6K)
3.64% more ownership
Funds ownership: 9.1% → 12.74% (+3.6%)
0% more funds holding
Funds holding: 1 → 1 (0)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$10.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.55K |
| 3 |
Renaissance Technologies
New York
|
-$3K |
| 4 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
-$1.44K |
| 5 |
HF
HRT Financial
New York
|
-$1K |
CRKN Hedge Fund Activity: Q2 2023 in Review
1 of the 6,384 institutional investors tracked by Wall St. Rank reported a position in Crown Electrokinetics Corp. Common Stock (CRKN) for Q2 2023, worth a combined $339K — up 28% from $265K a quarter earlier.
Fund positioning in CRKN was balanced in Q2 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Citigroup, cutting an estimated $10.7K.
- 1 institutional investor held Crown Electrokinetics Corp. Common Stock (CRKN) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $339K of Crown Electrokinetics Corp. Common Stock stock for Q2 2023, up 28% quarter-over-quarter.
- 0 funds opened new Crown Electrokinetics Corp. Common Stock positions in Q2 2023 and 0 closed out.
- The largest Crown Electrokinetics Corp. Common Stock seller in Q2 2023 was Citigroup, an estimated $10.7K sold.
Based on aggregated 13F filings for Q2 2023.